Ticker
ACE.ST

Price
21.00
Stock movement down
-0.65 (-3.00%)
Company name
Ascelia Pharma AB (publ)
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
707.03M
Ent value
501.54M
Price/Sales
-
Price/Book
2.52
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-23.36%
3 year return
5.08%
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

ACE.ST does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.52
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count33.67M
EPS (TTM)-3.65
FCF per share (TTM)-3.62

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-136.78M
Net income (TTM)-126.16M
EPS (TTM)-3.65
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash232.60M
Net receivables6.77M
Total current assets249.14M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets307.50M
Accounts payable4.89M
Short/Current long term debt1.14M
Total current liabilities26.84M
Total liabilities27.11M
Shareholder's equity280.39M
Net tangible assets223.33M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-124.98M
Capital expenditures (TTM)178.00K
Free cash flow (TTM)-125.16M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-44.99%
Return on Assets-41.03%
Return on Invested Capital-44.86%
Cash Return on Invested Capital-44.50%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open21.65
Daily high22.05
Daily low20.70
Daily Volume47K
All-time high63.10
1y analyst estimate70.00
Beta0.73
EPS (TTM)-3.65
Dividend per share-
Ex-div date-
Next earnings date4 Nov 2022

Downside potential

Loading...
Downside potential data
ACE.STS&P500
Current price drop from All-time high-66.72%-12.18%
Highest price drop-69.45%-56.47%
Date of highest drop8 Mar 20229 Mar 2009
Avg drop from high-36.64%-11.38%
Avg time to new high48 days12 days
Max time to new high428 days1805 days
COMPANY DETAILS
ACE.ST (Ascelia Pharma AB (publ)) company logo
Marketcap
707.03M
Marketcap category
Small-cap
Description
Ascelia Pharma AB (publ), a biotech company, operates as an oncology-focused orphan drug development company in Sweden. It is developing Mangoral, a novel non-gadolinium contrast agent, which is in Phase 3 for use in MRI-scans of the liver; and Oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer. It has a clinical collaboration agreement with Taiho Oncology, Inc. for the development of Oncoral in combination with LONSURF. Ascelia Pharma AB (publ) was founded in 2000 and is headquartered in Malmö, Sweden.
Employees
21
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found